These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX. Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [Abstract] [Full Text] [Related]
23. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1. Shi W, Feng L, Dong S, Ning Z, Hua Y, Liu L, Chen Z, Meng Z. Cell Commun Signal; 2020 Jun 23; 18(1):100. PubMed ID: 32576198 [Abstract] [Full Text] [Related]
25. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells. You X, Liu F, Zhang T, Lv N, Liu Q, Shan C, Du Y, Kong G, Wang T, Ye L, Zhang X. Oncogene; 2014 Jan 23; 33(4):449-60. PubMed ID: 23318446 [Abstract] [Full Text] [Related]
26. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma. Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J. Oncol Rep; 2013 Sep 23; 30(3):1309-14. PubMed ID: 23828071 [Abstract] [Full Text] [Related]
27. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K. Cancer Res; 2016 Jun 01; 76(11):3265-76. PubMed ID: 27197151 [Abstract] [Full Text] [Related]
28. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo. Yao M, Wang L, Yang J, Yan X, Cai Y, Yao D. Tumour Biol; 2016 Nov 01; 37(11):14677-14686. PubMed ID: 27623941 [Abstract] [Full Text] [Related]
29. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H. Tumour Biol; 2016 Oct 01; 37(10):13521-13531. PubMed ID: 27465557 [Abstract] [Full Text] [Related]
30. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. Zheng YH, Hu WJ, Chen BC, Grahn TH, Zhao YR, Bao HL, Zhu YF, Zhang QY. Liver Int; 2016 Dec 01; 36(12):1836-1847. PubMed ID: 27246112 [Abstract] [Full Text] [Related]
31. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma. Ni F, Zhao H, Cui H, Wu Z, Chen L, Hu Z, Guo C, Liu Y, Chen Z, Wang X, Chen D, Wei H, Wang S. Cancer Lett; 2015 Jan 28; 356(2 Pt B):809-18. PubMed ID: 25449782 [Abstract] [Full Text] [Related]
32. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Yang Y, Hou N, Wang X, Wang L, Chang S, He K, Zhao Z, Zhao X, Song T, Huang C. Oncotarget; 2015 Jun 30; 6(18):16227-38. PubMed ID: 26023735 [Abstract] [Full Text] [Related]
33. RNA interference-mediated silencing of Stat5 induces apoptosis and growth suppression of hepatocellular carcinoma cells. Zhang L, Zhao Z, Feng Z, Yin N, Lu G, Shan B. Neoplasma; 2012 Jun 30; 59(3):302-9. PubMed ID: 22296499 [Abstract] [Full Text] [Related]
34. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC. Cancer Res; 2013 Sep 01; 73(17):5580-90. PubMed ID: 23832667 [Abstract] [Full Text] [Related]
35. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling. Zhang H, Tian Y, Shen J, Wang Y, Xu Y, Wang Y, Han Z, Li X. Int J Oncol; 2014 Aug 01; 45(2):719-31. PubMed ID: 24899407 [Abstract] [Full Text] [Related]
36. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis. Chen HC, Jeng YM, Yuan RH, Hsu HC, Chen YL. Ann Surg Oncol; 2012 Jun 01; 19(6):2011-9. PubMed ID: 22146883 [Abstract] [Full Text] [Related]
37. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Qiu MT, Fan Q, Zhu Z, Kwan SY, Chen L, Chen JH, Ying ZL, Zhou Y, Gu W, Wang LH, Cheng WW, Zeng J, Wan XP, Mok SC, Wong KK, Bao W. Oncotarget; 2015 Oct 13; 6(31):31702-20. PubMed ID: 26397136 [Abstract] [Full Text] [Related]
38. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells. Su JC, Chiang HC, Tseng PH, Tai WT, Hsu CY, Li YS, Huang JW, Ko CH, Lin MW, Chu PY, Liu CY, Chen KF, Shiau CW. Carcinogenesis; 2014 Dec 13; 35(12):2807-14. PubMed ID: 25322871 [Abstract] [Full Text] [Related]
39. Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients. Shi Z, Liu J, Yu X, Huang J, Shen S, Zhang Y, Han R, Ge N, Yang Y. Ann Surg Oncol; 2016 Jan 13; 23(1):211-7. PubMed ID: 25824262 [Abstract] [Full Text] [Related]
40. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. Bai HY, Liao YJ, Cai MY, Ma NF, Zhang Q, Chen JW, Zhang JX, Wang FW, Wang CY, Chen WH, Jin XH, Xu RH, Guan XY, Xie D. Stem Cells; 2018 Feb 13; 36(2):180-191. PubMed ID: 29119708 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]